Pharma Mar | PHM - Current Liabilities


Pharma Mar reported EUR98.42M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Akebia Therapeutics USD 160.86M 13.02M Jun/2026
Alaunos Therapeutics USD 595K 218K Mar/2026
Almirall EUR 323.65M 26.99M Jun/2026
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 34.39M 3.89M Jun/2026
Ionis Pharmaceuticals USD 315.64M 401.36M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Moderna USD 2.53B 139M Jun/2026
Organon & Co USD 2.62B 116M Jun/2026
Pharma Mar EUR 98.42M 9.2M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Viatris USD 6.35B 464.5M Jun/2026
Xeris Pharmaceuticals USD 189.57M 70.97M Jun/2026